Managers' transactions - Anat Loewenstein
Revenio Group Corporation | Stock Exchange Release | September 21, 2026 at 17:00:00 EEST
Person subject to the notification requirement
Name: Loewenstein, Anat
Position: Member of the Board/Deputy member
Issuer: Revenio Group Oyj
LEI: 743700I27E0FWSXLKK04
Notification type: INITIAL NOTIFICATION
Reference number: 743700I27E0FWSXLKK04_20260921133624_8
____________________________________________
Transaction date: 2026-09-21
Venue not applicable
Instrument type: SHARE
ISIN: FI0009010912
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details (1):
Volume: 1054
Unit price: 0.00 EUR
Aggregated transactions (1):
Volume: 1054
Volume weighted average price: 0.00 EUR
For further information, please contact
CFO Jukka Kainulainen
+358 9 8775 1150
ir@revenio.fi
Distribution
Nasdaq Helsinki Oy
Financial Supervisory Authority (FIN-FSA)
Principal media
www.reveniogroup.fi/en
Revenio Group in brief
Revenio is a leading turnkey solutions provider in the global eye care market. The group offers fast, user-friendly, and reliable tools for diagnosing a wide variety of eye diseases. Revenio’s solutions include e.g. tonometers, fundus imaging devices, optical coherence tomography (OCT), perimeters, multimodal devices, refraction systems, and software solutions under iCare and Visionix.
In May 2026, Revenio joined forces with Visionix, creating the most innovative, creative and comprehensive entity serving eye care professionals across optometry, optical retail and ophthalmology. In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. In 2025, the Group’s pro forma net sales totaled EUR 252.8 million, with a pro forma adjusted EBITDA of EUR 45.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.